SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Zymergen Inc. (ZY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 25/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ZY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio10.78
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-4.87
Book Value / Share$0.00
Revenue / Share$0.23
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-2.42 |
$15.42M |
$-236.8M |
-1535.8% |
| 2020 |
$-2.68 |
$13.28M |
$-262.19M |
-1973.8% |
| 2021 |
$-4.87 |
$16.74M |
$-361.79M |
-2160.8% |
